Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01650922
First received: July 24, 2012
Last updated: July 25, 2012
Last verified: July 2012
  Purpose

To look for patterns of polymorphisms in DNA repair in both germline and tumor cells samples.


Condition Intervention
Brain Cancer
Procedure: phlebotomy
Procedure: biopsy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples

Resource links provided by NLM:


Further study details as provided by Stanford University:

Biospecimen Retention:   Samples With DNA

the investigators will sample a single blood sample or buccal swab and if obtained at the time of diagnosis, brain tumor biopsy.


Enrollment: 4
Study Start Date: September 2005
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   up to 24 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pediatric cancer patients diagnosed with brain tumors

Criteria

Inclusion Criteria:Pediatric cancer patients diagnosed with brain tumors

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01650922

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: James M Ford Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01650922     History of Changes
Other Study ID Numbers: PEDSBRN0004, 96447, PEDSBRN0004
Study First Received: July 24, 2012
Last Updated: July 25, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
Neoplasms by Site
Neoplasms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on August 01, 2014